Human challenge study to assess CDI-988 in norovirus-infected subjects
Latest Information Update: 13 Jan 2025
Price :
$35 *
At a glance
- Drugs CDI 988 (Primary)
- Indications Norovirus infections
- Focus Therapeutic Use
- 13 Jan 2025 New trial record
- 08 Jan 2025 According to a Cocrystal Pharma Inc media release, company will initiate a human challenge study in norovirus-infected subjects later in 2025.